BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12054101)

  • 1. Small molecules in anti-angiogenic therapy.
    Giavazzi R; Nicoletti MI
    Curr Opin Investig Drugs; 2002 Mar; 3(3):482-91. PubMed ID: 12054101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis inhibitors. New anticancer strategy.
    Zgodziński W; Wallner G; Dabrowski A
    Pol J Pharmacol; 1999; 51(6):455-62. PubMed ID: 10817522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.
    Hall AP; Westwood FR; Wadsworth PF
    Toxicol Pathol; 2006; 34(2):131-47. PubMed ID: 16537292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis: basic and clinical aspects.
    Ribatti D; Vacca A; Nico B; Presta M; Roncali L
    Ital J Anat Embryol; 2003; 108(1):1-24. PubMed ID: 12737512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiogenesis and anti-angiogenic strategies for glioblastoma].
    de Boüard S; Guillamo JS
    Bull Cancer; 2005 Apr; 92(4):360-72. PubMed ID: 15888393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-angiogenic drugs: from bench to clinical trials.
    Quesada AR; Muñoz-Chápuli R; Medina MA
    Med Res Rev; 2006 Jul; 26(4):483-530. PubMed ID: 16652370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in neuroblastoma.
    Ribatti D; Marimpietri D; Pastorino F; Brignole C; Nico B; Vacca A; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():133-42. PubMed ID: 15650239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and matrikines in angiogenesis.
    Bellon G; Martiny L; Robinet A
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):203-20. PubMed ID: 15036261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice?
    Mancuso A; Sternberg CN
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):67-81. PubMed ID: 15890525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
    Ellis LM
    Am Surg; 2003 Jan; 69(1):3-10. PubMed ID: 12575772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrins: the keys to unlocking angiogenesis.
    Silva R; D'Amico G; Hodivala-Dilke KM; Reynolds LE
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1703-13. PubMed ID: 18658045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new family of angiogenic factors.
    Martínez A
    Cancer Lett; 2006 May; 236(2):157-63. PubMed ID: 15927357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of matrix metalloproteinases and their tissue inhibitors in angiogenesis].
    Bogaczewicz J; Dudek W; Zubilewicz T; Wroński J; Przywara S; Chodorowska G; Krasowska D
    Pol Merkur Lekarski; 2006 Jul; 21(121):80-5. PubMed ID: 17007300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.